Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7250)
All Articles published online
|
Publishing Process of This Article
|
Nov 6, 2014 (publication date) through Jan 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Katayama K, Nomura S, Tryggvason K, Ito M. Searching for a treatment for Alport syndrome using mouse models. World J Nephrol 2014; 3(4): 230-236 [PMID: 25374816 DOI: 10.5527/wjn.v3.i4.230] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v3/i4/230.htm |
| Number | Citing Articles |
| 1 |
Manami Iida, Shuichi Ohtomo, Naoko A. Wada, Otoya Ueda, Yoshinori Tsuboi, Atsuo Kurata, Kou-ichi Jishage, Naoshi Horiba, Franziska Theilig. TNF-α induces Claudin-1 expression in renal tubules in Alport mice. PLOS ONE 2022; 17(3): e0265081 doi: 10.1371/journal.pone.0265081
|
| 2 |
Emilia Anouk Margo Firat, Eva Miriam Buhl, Nassim Bouteldja, Bart Smeets, Ulf Eriksson, Peter Boor, Barbara Mara Klinkhammer. PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome. The American Journal of Pathology 2024; 194(5): 641 doi: 10.1016/j.ajpath.2023.12.009
|
| 3 |
Avanti Adone, Ashish Anjankar. Alport Syndrome: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.47129
|
| 4 |
Matthew J. Williams, Toshifumi Sugatani, Olga A. Agapova, Yifu Fang, Joseph P. Gaut, Marie-Claude Faugere, Hartmut H. Malluche, Keith A. Hruska. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney International 2018; 93(1): 147 doi: 10.1016/j.kint.2017.06.016
|
| 5 |
Examining the Causal Relationship Between Genes, Epigenetics, and Human Health. Advances in Bioinformatics and Biomedical Engineering 2019; : 361 doi: 10.4018/978-1-5225-8066-9.ch015
|
| 6 |
Guozhen Wang, Mengqiu Liao, Danny Junyi Tan, Xiangjun Chen, Ran Chao, Yifan Zhu, Pan Li, Yuelin Guan, Jianhua Mao, Lidan Hu. Advances in Diagnosis and Treatment of Inherited Kidney Diseases in Children. Kidney Diseases 2024; : 1 doi: 10.1159/000541564
|
| 7 |
Andreas F. Hofmeister, Martin Kömhoff, Stefanie Weber, Ivica Grgic. Disease modeling in genetic kidney diseases: mice. Cell and Tissue Research 2017; 369(1): 159 doi: 10.1007/s00441-017-2639-3
|
| 8 |
S. Pinto, M. Hoek, Y. Huang, P. Costet, L. Ma, J.E. Imbriglio. Comprehensive Medicinal Chemistry III. 2017; : 694 doi: 10.1016/B978-0-12-409547-2.12432-1
|
| 9 |
Tomohiro Murata, Kan Katayama, Toshitaka Oohashi, Timo Jahnukainen, Tomoko Yonezawa, Yoshikazu Sado, Eiji Ishikawa, Shinsuke Nomura, Karl Tryggvason, Masaaki Ito. COL4A6 is dispensable for autosomal recessive Alport syndrome. Scientific Reports 2016; 6(1) doi: 10.1038/srep29450
|
| 10 |
Camila I. Irion, Monique Williams, Jose Condor Capcha, Trevor Eisenberg, Guerline Lambert, Lauro M. Takeuchi, Grace Seo, Keyvan Yousefi, Rosemeire Kanashiro-Takeuchi, Keith A. Webster, Karen C. Young, Joshua M. Hare, Lina A. Shehadeh. Col4a3-/- Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds. International Journal of Molecular Sciences 2022; 23(12): 6674 doi: 10.3390/ijms23126674
|
| 11 |
Jifan Guo, Wenping Song, Joseph Boulanger, Ethan Y. Xu, Fang Wang, Yanqin Zhang, Qun He, Suxia Wang, Li Yang, Cynthia Pryce, Lucy Phillips, Deidre MacKenna, Ekkehard Leberer, Oxana Ibraghimov-Beskrovnaya, Jie Ding, Shiguang Liu. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome. Human Gene Therapy 2019; 30(7): 865 doi: 10.1089/hum.2018.205
|
| 12 |
Yuan Wu, Yi Guo, Jinzhong Yuan, Hongbo Xu, Yong Chen, Hao Zhang, Mingyang Yuan, Hao Deng, Lamei Yuan. A COL4A5 Missense Variant in a Han-Chinese Family with X-linked Alport Syndrome. Current Molecular Medicine 2019; 19(10): 758 doi: 10.2174/1566524019666190906144214
|
| 13 |
Jianqing Liang, Youhua Liu. Animal Models of Kidney Disease: Challenges and Perspectives. Kidney360 2023; 4(10): 1479 doi: 10.34067/KID.0000000000000227
|
| 14 |
Valerie S LeBleu, Keizo Kanasaki, Sara Lovisa, Joseph L Alge, Jiha Kim, Yang Chen, Yingqi Teng, Behzad Gerami-Naini, Hikaru Sugimoto, Noritoshi Kato, Ignacio Revuelta, Nicole Grau, Jonathan P Sleeman, Gangadhar Taduri, Akane Kizu, Shahin Rafii, Konrad Hochedlinger, Susan E Quaggin, Raghu Kalluri. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome. Life Science Alliance 2024; 7(6): e202402664 doi: 10.26508/lsa.202402664
|
| 15 |
Daniel P. Gale, Oliver Gross, Fang Wang, Rafael José Esteban de la Rosa, Matthew Hall, John A. Sayer, Gerald Appel, Ali Hariri, Shiguang Liu, Manish Maski, Yuqian Shen, Qi Zhang, Sajida Iqbal, Madhurima Uppara Kowthalam, Julie Lin, Jie Ding. A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome. Clinical Journal of the American Society of Nephrology 2024; 19(8): 995 doi: 10.2215/CJN.0000000000000458
|